SCHEMBL6216192

SCHEMBL6216192

CCOC(=O)c1sc2nc(SC)nc(-c3ccccc3)c2c1N

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.62
▸ KDM4E B2RXH2 6/20 0.62
▸ MAPT P10636 5/20 0.62
▸ GAA P10253 2/20 0.62
▸ MAPK1 P28482 2/20 0.62
▸ L3MBTL1 Q9Y468 2/20 0.62
▸ LHCGR P22888 5/20 0.59
▸ HSD17B10 Q99714 2/20 0.57
▸ HPGD P15428 3/20 0.56
▸ SMN1; SMN2 Q16637 2/20 0.56
▸ NPC1 O15118 2/20 0.56
▸ RAB9A P51151 2/20 0.56
▸ HTT P42858 1/20 0.54
▸ TSHR P16473 2/20 0.53
▸ GLA P06280 1/20 0.53
▸ CASP1 P29466 1/20 0.53
▸ CASP7 P55210 1/20 0.53
▸ ATM Q13315 1/20 0.53
▸ TDP1 Q9NUW8 1/20 0.48
▸ CDC7 O00311 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6217590 0.91 LHCGR (0.53) ALDH1A1KDM4EMAPTGAAMAPK1
SCHEMBL6216763 0.91 KDM4E (0.61) ALDH1A1KDM4EMAPTGAAMAPK1
SCHEMBL4431522 0.90 LHCGR (0.62) ALDH1A1KDM4EMAPTGAAMAPK1
SCHEMBL6220445 0.90 LHCGR (0.65) ALDH1A1KDM4EMAPTGAAMAPK1
SCHEMBL6217061 0.90 LHCGR (0.57) ALDH1A1KDM4EMAPTGAAMAPK1
SCHEMBL6214494 0.90 LHCGR (0.59) ALDH1A1KDM4EMAPTGAAMAPK1
SCHEMBL6216798 0.90 LHCGR (0.52) ALDH1A1KDM4EMAPTGAAMAPK1
SCHEMBL6216322 0.88 ALDH1A1 (0.52) ALDH1A1KDM4EMAPTGAAMAPK1
SCHEMBL4327613 0.88 LHCGR (0.77) ALDH1A1KDM4EMAPTGAAMAPK1
SCHEMBL2131332 0.88 LHCGR (0.61) ALDH1A1KDM4EMAPTGAAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1171443-B1 BICYCLIC HETEROAROMATIC COMPOUNDS USEFUL AS LH AGONISTS AKZO NOBEL NV (NL) 2005-07-13 — — EP claimed
US-6841553-B2 Bicyclic heteroaromatic compounds useful as LH agonists AKZO NOBEL N.V. (NL) 2005-01-11 — — US claimed
US-20030212081-A1 Bicyclic heteroaromatic compounds useful as LH agonists MERCK SHARP & DOHME B.V. (NL) 2003-11-13 — — US claimed
EP-1171443-B1 BICYCLIC HETEROAROMATIC COMPOUNDS USEFUL AS LH AGONISTS AKZO NOBEL NV (NL) 2005-07-13 — — EP disclosed
US-6841553-B2 Bicyclic heteroaromatic compounds useful as LH agonists AKZO NOBEL N.V. (NL) 2005-01-11 — — US disclosed
US-20030212081-A1 Bicyclic heteroaromatic compounds useful as LH agonists MERCK SHARP & DOHME B.V. (NL) 2003-11-13 — — US disclosed
US-6569863-B1 Luteinizing hormone (LH) agonists for controlling fertility AKZO NOBEL NV (NL) 2003-05-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030212081-A1 Bicyclic heteroaromatic compounds useful as LH agonists LHCGR, GNRHR, FSHR ALDH1A1 757/4885KDM4E 2123/4885MAPT 4619/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback